237 related articles for article (PubMed ID: 9263460)
1. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
3. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
[TBL] [Abstract][Full Text] [Related]
4. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.
Iseki H; Ko TC; Xue XY; Seapan A; Hellmich MR; Townsend CM
Surgery; 1997 Aug; 122(2):187-94; discussion 194-5. PubMed ID: 9288122
[TBL] [Abstract][Full Text] [Related]
6. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
8. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.
Abraham RT; Acquarone M; Andersen A; Asensi A; Bellé R; Berger F; Bergounioux C; Brunn G; Buquet-Fagot C; Fagot D
Biol Cell; 1995; 83(2-3):105-20. PubMed ID: 7549905
[TBL] [Abstract][Full Text] [Related]
9. G2-and early-M-specific expression of the NTCYC1 cyclin gene in Nicotiana tabacum cells.
Qin LX; Perennes C; Richard L; Bouvier-Durand M; Tréhin C; Inzé D; Bergounioux C
Plant Mol Biol; 1996 Dec; 32(6):1093-101. PubMed ID: 9002608
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.
Legraverend M; Ludwig O; Bisagni E; Leclerc S; Meijer L; Giocanti N; Sadri R; Favaudon V
Bioorg Med Chem; 1999 Jul; 7(7):1281-93. PubMed ID: 10465404
[TBL] [Abstract][Full Text] [Related]
11. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions.
Glab N; Labidi B; Qin LX; Trehin C; Bergounioux C; Meijer L
FEBS Lett; 1994 Oct; 353(2):207-11. PubMed ID: 7523194
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor roscovitine induces cell cycle arrest and apoptosis in rabbit retinal pigment epithelial cells.
Wu PC; Tai MH; Hu DN; Lai CH; Chen YH; Wu YC; Tsai CL; Shin SJ; Kuo HK
J Ocul Pharmacol Ther; 2008 Feb; 24(1):25-33. PubMed ID: 18370874
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
David-Pfeuty T
Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
[TBL] [Abstract][Full Text] [Related]
14. Evidence that Fas-induced apoptosis leads to S phase arrest.
N'cho M; Brahmi Z
Hum Immunol; 2001 Apr; 62(4):310-9. PubMed ID: 11295463
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Vicia faba root tip cells with specific inhibitors to cyclin-dependent kinases leads to abnormal spindle formation.
Binarová P; Dolezel J; Draber P; Heberle-Bors E; Strnad M; Bögre L
Plant J; 1998 Dec; 16(6):697-707. PubMed ID: 10069076
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
Matsumoto Y; Hayashi K; Nishida E
Curr Biol; 1999 Apr; 9(8):429-32. PubMed ID: 10226033
[TBL] [Abstract][Full Text] [Related]
17. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
Schang LM; Phillips J; Schaffer PA
J Virol; 1998 Jul; 72(7):5626-37. PubMed ID: 9621021
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle regulation of cyclin-dependent kinases in tobacco cultivar Bright Yellow-2 cells.
Sorrell DA; Menges M; Healy JM; Deveaux Y; Amano C; Su Y; Nakagami H; Shinmyo A; Doonan JH; Sekine M; Murray JA
Plant Physiol; 2001 Jul; 126(3):1214-23. PubMed ID: 11457971
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulation by plant growth regulators: involvement of auxin and cytokinin in the re-entry of Petunia protoplasts into the cell cycle.
Tréhin C; Planchais S; Glab N; Perennes C; Tregear J; Bergounioux C
Planta; 1998 Oct; 206(2):215-24. PubMed ID: 9737000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]